Sold as Sotradecol. Every FDA application for this active ingredient: 1 branded and 2 generic.
As of Nov 22, 2026, FDA lists 3 applications for Sodium tetradecyl sulfate (sold as Sotradecol), first approved Aug 13, 1946, with 0 new uses approved and 0 published complete response letters.
| Aug 13, 1946 | SotradecolNDA 5970 ยท New molecular entity | Elkins-Sinn | 17 | Discontinued |
| Nov 12, 2004 | SotradecolANDA 40541 | Mylan Institutional | 3 | Marketed |
| Dec 9, 2019 | Sodium Tetradecyl SulfateANDA 209937 | Hikma Pharmaceuticals | 0 | Marketed |
| Endoscopic Shunts Embolization for Refractory Hepatic EncephalopathyHepatic Encephalopathy, Liver Cirrhosis ยท Rutgers, The State University of New Jersey | Not applicable | Not yet recruiting | Apr 28, 2026 |
| Study Comparing Glycerin With 1% Lidocaine and Epinephrine Versus Glycerin With 1% Lidocaine Without Epinephrine for the Sclerotherapy of Leg TelangiectasiasLeg Veins ยท Goldman, Butterwick, Fitzpatrick and Groff | Phase 4 | Not yet recruiting | Jan 15, 2026 |
| Endoscopic Ultrasound-guided Cyanoacrylate Injection Versus Balloon-Occluded Retrograde Transvenous Obliteration in Managing Patients With Gastric VaricesGastric Varix ยท Assiut University | Not applicable | Active, not recruiting | Aug 15, 2022 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Mechanisms, targets, withdrawals and boxed warnings are from ChEMBL (EMBL-EBI, CC BY-SA 3.0), matched by ingredient name. How trials ended is TrialPanorama's classification of ClinicalTrials.gov records (Wang et al. 2025, Apache-2.0), matched by the intervention name each trial registered. Drugs@FDA